Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA drug regulation workshop

Executive Summary

FDA will hold a two-day public meeting June 8-9 to provide information about drug and device regulation to the regulated industry. Called "Drugs and Devices - Promoting and Protecting the Public Health Through Risk Management and Product Cycle Improvement," the workshop will address: a risk management approach to consumer protection and industry regulation; how quality management systems (including corrective and preventive action) contribute to product cycle improvement; supplier management and component controls for drugs and devices; adverse drug event reporting requirements; medical device reporting requirements; recalls, corrections and removals; and complaint handling from the FDA investigator's perspective
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS050906

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel